NEW YORK (GenomeWeb News) – Knome has raised almost $5.8 million toward a targeted goal of $6.3 million, the bioinformatics firm said recently in a regulatory document.

The company did not respond to a request for comment. It did not say in its Form D filed with the US Securities and Exchange Commission who the investors are or how the funds would be used.

The securities offered were in the form of debt.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.